1267166-99-3

Upstream product

• 152713-78-5 ethyl 2-bromo-3-(2-chlorophenyl)-3-oxopropanoate 
• 1426521-20-1 ethyl 2-(2-chlorophenyl)imidazo[1,2-a]pyridine-3-carboxylate 
• 504-29-0 2-aminopyridine 

Downstream Products

• 1426521-40-5 2-(2-chlorophenyl)-N-(4-chlorophenyl)imidazo[1,2-a]pyridine-3-carbothioamide 
• 1426521-38-1 2-(2-chlorophenyl)-N-(4-chlorophenyl)imidazo[1,2-a]pyridine-3-carbohydrazonamide 
• 1426521-56-3 2-(2-chlorophenyl)-3-(1-(4-chlorophenyl)-1H-tetrazol-5-yl)imidazo[1,2-a]pyridine 
• 1426521-57-4 2-(2-chlorophenyl)-3-(4-(4-chlorophenyl)-4H-1,2,4-triazol-3-yl)imidazo[1,2-a]pyridine 
• 1426521-39-2 2-(2-chlorophenyl)-N-(4-chlorophenyl)imidazo[1,2-a]pyridine-3-carboxamide 
• 1426521-59-6 2-(2-chlorophenyl)-3-(1-(4-chlorophenyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyridine 
• 1426521-41-6 2-(2-chlorophenyl)imidazo[1,2-a]pyridine-3-carboxamide 

Relevant academic research and scientific papers

BICYCLIC AGONISTS OF GPR131 AND USES THEREOF

The present disclosure relates to compounds that act as agonists of, or otherwise modulate the activity of, GPR131 and to their use in the treatment of various diseases. In particular embodiments, the structure of the compounds is given by Formula I: wherein the variables are as described herein. Related compositions, formulations and methods for the preparation of compounds of formula I are also described.